This company is no longer active
Graphite Bio Balance Sheet Health
Financial Health criteria checks 6/6
Graphite Bio has a total shareholder equity of $183.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $188.5M and $4.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$184.26m |
| Equity | US$183.58m |
| Total liabilities | US$4.87m |
| Total assets | US$188.46m |
Recent financial health updates
Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation
Sep 20
We're Hopeful That Graphite Bio (NASDAQ:GRPH) Will Use Its Cash Wisely
Jun 02Will Graphite Bio (NASDAQ:GRPH) Spend Its Cash Wisely?
Feb 01Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation
Oct 05Will Graphite Bio (NASDAQ:GRPH) Spend Its Cash Wisely?
Jun 22Graphite Bio (NASDAQ:GRPH) Is In A Good Position To Deliver On Growth Plans
Sep 25Recent updates
Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation
Sep 20We're Hopeful That Graphite Bio (NASDAQ:GRPH) Will Use Its Cash Wisely
Jun 02Will Graphite Bio (NASDAQ:GRPH) Spend Its Cash Wisely?
Feb 01Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation
Oct 05Graphite Bio doses first patient with GPH101 for sickle cell disease
Aug 11Will Graphite Bio (NASDAQ:GRPH) Spend Its Cash Wisely?
Jun 22Graphite Bio: Selling For Much Less Than Net Cash
May 25Graphite Bio: An Important Stock To Track In The Gene Editing Space
Nov 18Graphite Bio (NASDAQ:GRPH) Is In A Good Position To Deliver On Growth Plans
Sep 25Graphite Bio: Assessing Prospects Amid Doubts Raised On Safety Of Crispr
Aug 30Financial Position Analysis
Short Term Liabilities: GRPH's short term assets ($188.0M) exceed its short term liabilities ($4.8M).
Long Term Liabilities: GRPH's short term assets ($188.0M) exceed its long term liabilities ($77.0K).
Debt to Equity History and Analysis
Debt Level: GRPH is debt free.
Reducing Debt: GRPH had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GRPH has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: GRPH has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 44.7% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/03/21 11:43 |
| End of Day Share Price | 2024/03/21 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Graphite Bio, Inc. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Konstantinos Biliouris | BMO Capital Markets Equity Research |
| Gregory Harrison | BofA Global Research |
| Yun Zhong | BTIG |